Concepts (97)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Drosophila melanogaster | 4 | 2011 | 615 | 0.400 |
Why?
|
| Antigens | 1 | 2011 | 229 | 0.340 |
Why?
|
| Sequence Analysis, Protein | 1 | 2007 | 28 | 0.290 |
Why?
|
| Computational Biology | 2 | 2009 | 556 | 0.290 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 353 | 0.290 |
Why?
|
| Serine Endopeptidases | 1 | 2007 | 147 | 0.270 |
Why?
|
| Drosophila Proteins | 3 | 2010 | 511 | 0.230 |
Why?
|
| Chromatin | 4 | 2018 | 410 | 0.180 |
Why?
|
| Genome, Insect | 2 | 2011 | 78 | 0.170 |
Why?
|
| Sumoylation | 1 | 2018 | 18 | 0.150 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2015 | 78 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2016 | 132 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 429 | 0.140 |
Why?
|
| Azabicyclo Compounds | 1 | 2015 | 4 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2016 | 163 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 2015 | 60 | 0.120 |
Why?
|
| DNA Helicases | 1 | 2015 | 85 | 0.120 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 492 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2018 | 679 | 0.120 |
Why?
|
| Software | 2 | 2009 | 670 | 0.110 |
Why?
|
| Insulator Elements | 2 | 2011 | 7 | 0.110 |
Why?
|
| Pyridines | 1 | 2015 | 304 | 0.110 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 282 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2015 | 538 | 0.100 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2011 | 6 | 0.090 |
Why?
|
| Histones | 2 | 2018 | 345 | 0.090 |
Why?
|
| Transcription Factors | 3 | 2015 | 1671 | 0.090 |
Why?
|
| Molecular Sequence Annotation | 1 | 2011 | 71 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 2 | 2015 | 742 | 0.090 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 731 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2016 | 687 | 0.090 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2011 | 158 | 0.090 |
Why?
|
| Genome | 2 | 2009 | 395 | 0.080 |
Why?
|
| Chromosome Mapping | 2 | 2010 | 1079 | 0.070 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2007 | 28 | 0.070 |
Why?
|
| Enzymes | 1 | 2007 | 46 | 0.070 |
Why?
|
| Protein Interaction Mapping | 1 | 2007 | 81 | 0.070 |
Why?
|
| Estrogens | 1 | 2008 | 200 | 0.070 |
Why?
|
| Embryonic Development | 1 | 2007 | 79 | 0.070 |
Why?
|
| Multigene Family | 1 | 2007 | 202 | 0.070 |
Why?
|
| Gene Regulatory Networks | 1 | 2009 | 309 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2007 | 363 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2007 | 373 | 0.070 |
Why?
|
| Animals | 6 | 2016 | 27783 | 0.070 |
Why?
|
| Molecular Sequence Data | 2 | 2007 | 3031 | 0.060 |
Why?
|
| Epigenesis, Genetic | 3 | 2018 | 530 | 0.060 |
Why?
|
| Drosophila | 1 | 2010 | 523 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 1 | 2007 | 872 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2016 | 557 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 1465 | 0.050 |
Why?
|
| Evolution, Molecular | 1 | 2007 | 859 | 0.050 |
Why?
|
| RNA Interference | 2 | 2015 | 378 | 0.050 |
Why?
|
| Neoplasms | 1 | 2015 | 3053 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 137 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2615 | 0.040 |
Why?
|
| Protein Binding | 2 | 2016 | 1508 | 0.040 |
Why?
|
| Algorithms | 1 | 2007 | 1933 | 0.040 |
Why?
|
| Disease Progression | 2 | 2016 | 1493 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2018 | 117 | 0.040 |
Why?
|
| Acetylation | 1 | 2018 | 143 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 97 | 0.040 |
Why?
|
| Lentivirus | 1 | 2016 | 43 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2016 | 123 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2018 | 660 | 0.030 |
Why?
|
| Multiprotein Complexes | 1 | 2016 | 96 | 0.030 |
Why?
|
| Models, Biological | 2 | 2016 | 1771 | 0.030 |
Why?
|
| Sarcoma, Synovial | 1 | 2015 | 21 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 2015 | 98 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 2015 | 146 | 0.030 |
Why?
|
| Rhabdoid Tumor | 1 | 2015 | 21 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2015 | 95 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2015 | 83 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 405 | 0.030 |
Why?
|
| Catalysis | 1 | 2015 | 209 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 121 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 2015 | 391 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2016 | 237 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 374 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 216 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2008 | 3029 | 0.030 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2016 | 388 | 0.030 |
Why?
|
| Humans | 5 | 2018 | 91073 | 0.030 |
Why?
|
| Silencer Elements, Transcriptional | 1 | 2011 | 5 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2011 | 84 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2016 | 1695 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2016 | 1183 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2011 | 289 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2011 | 964 | 0.020 |
Why?
|
| Estrogen Receptor alpha | 1 | 2008 | 148 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2008 | 500 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2007 | 532 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2785 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 2329 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 2380 | 0.010 |
Why?
|
| Mice | 1 | 2016 | 11993 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2007 | 1384 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 2008 | 1559 | 0.010 |
Why?
|